Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of amiodarone on serum apixaban levels in Thai patients with atrial fibrillation
TCTR20201005003Recruiting
- Sponsor
- Faculty of Pharmacy, Silpakorn University
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of apixaban and amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Faculty of Pharmacy, Silpakorn University. Primary endpoint: Apixaban level and anti-factor Xa activity at 0, 3, and 8 hours. Started Oct 2020; status: recruiting.
02
Drugs
apixabanamiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20201005003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201005003.